{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ciclosporin",
          "name": "Ciclosporin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tildrakizumab",
          "name": "Tildrakizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_guselkumab",
          "name": "Guselkumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_risankizumab",
          "name": "Risankizumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ciclosporin",
          "type": "Drug",
          "label": "Ciclosporin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_guselkumab",
          "type": "Drug",
          "label": "Guselkumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_risankizumab",
          "type": "Drug",
          "label": "Risankizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gp_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_th17_pathway",
          "type": "Pathway",
          "label": "Th17 pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_immunomodulation",
          "type": "Pathway",
          "label": "Immunomodulation pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_inflammation",
          "type": "Phenotype",
          "label": "Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_skin_flare",
          "type": "Phenotype",
          "label": "Skin Flare",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_acitretin",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知促发Th17细胞网络"
        },
        {
          "source": "n_ciclosporin",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "免疫调节作用支持"
        },
        {
          "source": "n_methotrexate",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过免疫抑制改善病症"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "靶向IL-23，干预Th17反应"
        },
        {
          "source": "n_secukinumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接抑制IL-17"
        },
        {
          "source": "n_infliximab",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "TNF-α抑制剂，对应炎症"
        },
        {
          "source": "n_etanercept",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "也为TNF-α抑制剂"
        },
        {
          "source": "n_tildrakizumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "靶向IL-23，减轻症状"
        },
        {
          "source": "n_apremilast",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "磷酸二酯酶4抑制剂，有助于控制炎症"
        },
        {
          "source": "n_brodalumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向IL-17的单抗及其作用机制"
        },
        {
          "source": "n_guselkumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "靶向IL-23相关机制"
        },
        {
          "source": "n_risankizumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "针对IL-23的作用"
        },
        {
          "source": "n_th17_pathway",
          "target": "n_inflammation",
          "relation": "involved_in",
          "weight": 0.87,
          "agent": "Proponent",
          "rationale": "与炎症表型直接相关"
        },
        {
          "source": "n_inflammation",
          "target": "n_gp_psoriasis",
          "relation": "associated_with",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "炎症与广泛性脓疱型银屑病直接相关"
        },
        {
          "source": "n_immunomodulation",
          "target": "n_skin_flare",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "调节免疫反应对皮肤反应影响"
        },
        {
          "source": "n_skin_flare",
          "target": "n_gp_psoriasis",
          "relation": "associated_with",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "皮肤反应与疾病的临床表现一致"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Acitretin 和其他药物通过作用于 Th17 途径及免疫调节机制可用于治疗广泛性脓疱型银屑病",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "不同药物通过不同机制至少形成2条不相交路径来支持治疗该疾病的假设",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物有效成分能够有效到达靶组织并发挥作用"
    ],
    "uncertainties": [
      "各药物的具体反应和效果可能因个体差异而异"
    ],
    "next_focus_for_pi": [
      "是否进行对比各药物疗效的临床试验以确认机制的有效性"
    ]
  }
}